Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CF.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CM.11NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CM.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.11NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DN.3.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DN.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DN.3.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DJ.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DJ.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DJ.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBC.1.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBC.1.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBC.1.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CM.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CM.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BW.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BW.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BW.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.10.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.10.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.10.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FW.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FW.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FW.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CH.1.1.29NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CH.1.1.29NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1.1.29NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.55NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.55NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.55NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.14NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.14NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.35NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.35NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.35NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
A.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.422NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.422NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.422NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.56NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used